VeriMomVeriMom
HIGH RISK

Hamilelikte lithium carbonate kullanmaktan kaçınmalı mıyım? | VeriMom

ECHA’s Risk Assessment Committee adopted an opinion classifying lithium carbonate (CAS 554-13-2) as Reproductive Toxicity Category 1A (H360; effect on fertility/foetus) with effects via lactation (H362), which is harmonised-level evidence of reproductive/developmental hazard; clinical and animal literature also document placental transfer and neonatal/fetal effects for systemic (medicinal) lithium exposure. For topical cosmetic use systemic exposure is expected to be negligible (see ECHA registration dossier dermal absorption statement). (Sources: ECHA RAC CLH opinion; ECHA registration dossier; PubMed reviews/studies).

ECHA regulatory hazard statements

  • H360
  • H362

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

lithium carbonate hamilelikte güvenli mi?
ECHA’s Risk Assessment Committee adopted an opinion classifying lithium carbonate (CAS 554-13-2) as Reproductive Toxicity Category 1A (H360; effect on fertility/foetus) with effects via lactation (H362), which is harmonised-level evidence of reproductive/developmental hazard; clinical and animal literature also document placental transfer and neonatal/fetal effects for systemic (medicinal) lithium exposure. For topical cosmetic use systemic exposure is expected to be negligible (see ECHA registration dossier dermal absorption statement). (Sources: ECHA RAC CLH opinion; ECHA registration dossier; PubMed reviews/studies).
lithium carbonate emzirirken güvenli mi?
ECHA’s adopted opinion includes H362 (dangerous for or via breast‑feeding), and clinical data on medicinal lithium show lithium is excreted in human milk and can produce neonatal toxicity—supporting a high hazard (h=3) and demonstrated mechanism (m=2). For topical cosmetic applications, dermal absorption is considered very poor so direct exposure via cosmetic use is expected to be negligible, though systemic exposure from medicinal use is well documented. (Sources: ECHA RAC CLH opinion; ECHA registration dossier; product/labeling and clinical literature on lithium in breast milk).
lithium carbonate bebek cildi için güvenli mi?
Hazard and mechanism are driven by harmonised CLH (Repr.1A H360FD) and clinical/animal evidence of placental transfer and milk excretion—these apply to infants (h=3, m=2). Exposure (e) for topical cosmetic use is judged low/negligible in adults (ECHA: dermal absorption very poor), but infant skin has higher uptake potential so exposure is increased by +1 to e=1 as a precaution for 0–3‑year skin when the ingredient is present in topical products. There is no evidence that cosmetic-grade topical use produces systemic infant exposure, but the harmonised classification leads to conservative scoring for infant contexts. (Sources: ECHA RAC CLH opinion; ECHA registration dossier; PubMed clinical/animal studies).
VeriMom lithium carbonate nasıl puanlıyor?
VeriMom lithium carbonate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 27/100 (yüksek risk) olarak puanlar.
Hamilelikte lithium carbonate yerine neler kullanılabilir?
Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.

Her etiketi 2 saniyede kontrol et

VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.

Tıbbi Sorumluluk Reddi

Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.

VeriMom uygulamasında tüm özellikleri keşfedin